EW Stock Price | Edwards Lifesciences Corp P/E, Revenue, EPS, & Forecasts

Edwards Lifesciences Corp • EW

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Edwards Lifesciences Corp

Ticker

Trading on

NYSE

ISIN

US28176E1082

Industry

Medical Devices

Sector

Healthcare

CEO

Bernard J. Zovighian

Headquarters

One Edwards Way, Irvine, CA, United States, 92614

Employees

15,800

Website

edwards.com

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Metrics

BasicAdvanced

Market cap

$45B

P/E ratio

31.71

EPS

$2.42

Dividend Yield

0.00%

Beta

1.13

Forward P/E ratio

30.96

EBIDTA

$1.69B

Ex dividend date

Price & volume

Market cap

$45B

Average daily volume

4.7M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

31.71

Forward P/E

30.96

PEG ratio

4.21

Trailing P/E

31.71

Price to sales

8.15

Price to book

4.37

Earnings

EPS

$2.42

EPS estimate (current quarter)

$0.60

EPS estimate (next quarter)

$0.62

EBITDA

$1.69B

Revenues (TTM)

$5.52B

Revenues per share (TTM)

$9.30

Technicals

Beta

1.13

52-week High

$95.25

52-week Low

$58.93

50-day moving average

$71.74

200-day moving average

$70.07

Short ratio

1.54

Short %

1.60%

Management effectiveness

ROE (TTM)

16.51%

ROA (TTM)

8.42%

Profit margin

75.71%

Gross profit margin

$4.39B

Operating margin

29.02%

Growth

Quarterly earnings growth (YoY)

4.20%

Quarterly revenue growth (YoY)

6.20%

Share stats

Outstanding Shares

587M

Float

580M

Insiders %

0.92%

Institutions %

89.00%

Analyst Insights & forecasts

46% Buy

51% Hold

3% Sell

Based on information from 33 analysts.

Average price target

$80.40

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

$0.70

$0.69

1.45%

Q2 • 24Beat

$0.67

$0.64

4.69%

Q3 • 24Beat

$0.59

$0.55

6.38%

Q4 • 24Beat

$0.64

$0.60

7.45%

Q1 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$1.39B

$386M

27.83%

Q4 • 24

$1.41B

$358M

25.34%

Q1 • 25

1.94%

7.16%

8.93%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$13.1B

$2.99B

22.92%

Q4 • 24

$13B

$2.83B

21.74%

Q1 • 25

0.25%

5.40%

5.16%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-128M

$-577M

$28.6M

$-177M

Q4 • 24

$280M

$85.3M

$-258M

$224M

Q1 • 25

319.92%

114.79%

1,002.10%

226.57%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Edwards Lifesciences Corp share?

Edwards Lifesciences Corp shares are currently traded for undefined per share.

How many shares does Edwards Lifesciences Corp have?

Edwards Lifesciences Corp currently has 587M shares.

Does Edwards Lifesciences Corp pay dividends?

No, Edwards Lifesciences Corp doesn't pay dividends.

What is Edwards Lifesciences Corp 52 week high?

Edwards Lifesciences Corp 52 week high is $95.25.

What is Edwards Lifesciences Corp 52 week low?

Edwards Lifesciences Corp 52 week low is $58.93.

What is the 200-day moving average of Edwards Lifesciences Corp?

Edwards Lifesciences Corp 200-day moving average is $70.07.

Who is Edwards Lifesciences Corp CEO?

The CEO of Edwards Lifesciences Corp is Bernard J. Zovighian.

How many employees Edwards Lifesciences Corp has?

Edwards Lifesciences Corp has 15,800 employees.

What is the market cap of Edwards Lifesciences Corp?

The market cap of Edwards Lifesciences Corp is $45B.

What is the P/E of Edwards Lifesciences Corp?

The current P/E of Edwards Lifesciences Corp is 31.71.

What is the EPS of Edwards Lifesciences Corp?

The EPS of Edwards Lifesciences Corp is $2.42.

What is the PEG Ratio of Edwards Lifesciences Corp?

The PEG Ratio of Edwards Lifesciences Corp is 4.21.

What do analysts say about Edwards Lifesciences Corp?

According to the analysts Edwards Lifesciences Corp is considered a hold.